Cardiac Disease
Conditions
Keywords
Exercise, cardiac rehabilitation, quality of life
Brief summary
Outcomes evaluation is a critical component in outpatient cardiac rehabilitation. The aim of this study is to examine factors who predict long-term effects of improved peak oxygen uptake one year after participating in cardiac rehabilitation. Secondary to evaluate the short and long-term outcome of a 12-week outpatient cardiac rehabilitation program.
Detailed description
A prospective cohort study including all cardiac patients referred for outpatient cardiac rehabilitation in a primary care clinic in Oslo. The main efficacy variable is the changes in exercise capacity (VO2peak) as a primary prognostic measure of successful rehabilitation. HRQoL are measured by self-report using the COOP/WONCA questionnaire and SF-36.
Interventions
Group-based high-intensity aerobic interval training and lifestyle counseling
Sponsors
Study design
Eligibility
Inclusion criteria
* stable coronary heart disease * valvular surgery * refered to high-intensity exercise training from a cardiologist
Exclusion criteria
* acute myocardial infarction within four week * serious rhythm disturbances * unstable angina pectoris * known significant comorbidity * symptomatic peripheral vascular disease * obstructive pulmonary disease with forced expiratory vital capacity \< 60% of predicted * left ventricular ejection fraction \< 40%
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in peak oxygen uptake | baseline, 15 months | Change from baseline in peak oxygen uptake at 15 months |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Health related quality of life | baseline, 12 weeks | Changes from baseline in quality of life (COOP/WONCA and SF-36) at 12 weeks |
| Peak oxygen uptake | baseline, 12 weeks | Change from baseline in peak oxygen uptake at 12 weeks |
| Time to exhaustion | baseline, 15 months | Change from baseline in time to exhaustion at 15 months |
Other
| Measure | Time frame | Description |
|---|---|---|
| Systolic and diastolic Blood Pressure | baseline, 12 weeks | Changes from baseline in systolic and diastolic blood pressure at 12 weeks |
Countries
Norway